#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3092	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2461	374.4	0	.	n	.	0	A662G	SNP	662	662	A	1123	1123	G	466	G	390	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3092	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2461	374.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1911	1911	T	451	T	405	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3092	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2461	374.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1645	1645	C	430	C	381	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5236	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3848	407.8	0	.	n	.	0	G262A	SNP	262	262	G	772	772	A	448	A	401	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5236	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3848	407.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1847	1847	A	465	A	416	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5236	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3848	407.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2481	2481	C	517	C	448	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5236	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3848	407.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2555	2555	A	528	A,G	461,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5236	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3848	407.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3107	3107	C	472	C,A	406,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	404	folP	852	852	99.77	folP.l6.c4.ctg.1	1805	67.0	0	.	p	.	0	A204V	NONSYN	610	612	GCA	1093	1095	GTA	82;82;83	G;T;A	71;72;70	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	404	folP	852	852	99.77	folP.l6.c4.ctg.1	1805	67.0	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGC	1165	1167	AGC	79;79;79	A;G;C	67;68;66	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1038	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3711	84.0	1	SNP	p	S91F	0	.	.	271	273	TCC	706	708	TCC	89;90;90	T;C;C	83;83;83	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1038	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3711	84.0	1	SNP	p	D95N	0	.	.	283	285	GAC	718	720	GAC	88;88;88	G;A;C	79;78;80	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1038	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3711	84.0	1	SNP	p	D95G	0	.	.	283	285	GAC	718	720	GAC	88;88;88	G;A;C	79;78;80	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	370	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1632	68.1	0	.	p	.	0	D171G	NONSYN	511	513	GAC	1025	1027	GGC	100;100;101	G;G;C	87;86;87	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	370	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1632	68.1	1	SNP	p	G45D	0	.	.	133	135	GGC	647	649	GGC	97;97;96	G;G;C	83;81;81	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	220	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1240	53.3	0	.	n	.	0	.206T	INS	206	206	T	704	704	T	103	T	79	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	994	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3310	89.9	0	.	p	.	0	G459S	NONSYN	1375	1377	GGT	1845	1847	AGT	115;115;115	A;G;T	100;100;100	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	994	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3310	89.9	1	SNP	p	D86N	0	.	.	256	258	GAC	726	728	GAC	110;110;110	G;A;C,A	98;96;97,1	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	994	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3310	89.9	1	SNP	p	S87I	0	.	.	259	261	AGT	729	731	AGT	110;110;109	A;G;T	94;97;96	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	994	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3310	89.9	1	SNP	p	S87W	0	.	.	259	261	AGT	729	731	AGT	110;110;109	A;G;T	94;97;96	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	994	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3310	89.9	1	SNP	p	S87R	0	.	.	259	261	AGT	729	731	AGT	110;110;109	A;G;T	94;97;96	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	994	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3310	89.9	1	SNP	p	S88P	0	.	.	262	264	TCC	732	734	TCC	109;109;110	T;C;C	95;96;99	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	770	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3051	75.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1753	1755	GGC	97;97;99	G;G;C	90;84;87	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	766	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2789	82.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1491	1493	GCA	95;95;95	G;C;A	85;88;88	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	766	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2789	82.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1494	1496	ATC	95;95;96	A;T;C	88;89;88	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	766	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2789	82.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1506	1508	GTG	101;101;101	G;T,C;G	89;89,1;88	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	766	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2789	82.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1506	1508	GTG	101;101;101	G;T,C;G	89;89,1;88	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	766	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2789	82.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2010	2012	ACC	99;99;100	A,C;C;C,T	81,2;86;85,1	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	766	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2789	82.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2064	2066	GCG	93;93;93	G;C;G	82;76;76	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	766	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2789	82.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2064	2066	GCG	93;93;93	G;C;G	82;76;76	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	766	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2789	82.3	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2187	2189	GGT	89;89;89	G;G;T	77;80;79	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	766	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2789	82.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2196	2198	GGC	87;86;86	G;G;C	77;79;77	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	766	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2789	82.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2214	2216	CCG	88;88;88	C;C;G	75;77;75	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1022	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3399	90.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	484	porA	1146	1146	99.56	porA.l15.c17.ctg.1	2043	71.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	512	514	GGC	84;84;85	G;G;C	72;74;74	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	484	porA	1146	1146	99.56	porA.l15.c17.ctg.1	2043	71.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	694	694	C	80	C	69	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	570	porB1b	1041	1041	96.85	porB1b.l15.c17.ctg.1	1909	88.7	0	.	p	.	0	T18M	NONSYN	52	54	ACG	584	586	ATG	114;114;114	A;T;G	94;94;91	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	570	porB1b	1041	1041	96.85	porB1b.l15.c17.ctg.1	1909	88.7	0	.	p	.	0	T26A	NONSYN	76	78	ACC	608	610	GCC	109;110;110	G;C;C	91;93;94	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	570	porB1b	1041	1041	96.85	porB1b.l15.c17.ctg.1	1909	88.7	0	.	p	.	0	K41D	NONSYN	121	123	AAA	653	655	GAC	112;112;112	G;A;C	99;98;99	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	570	porB1b	1041	1041	96.85	porB1b.l15.c17.ctg.1	1909	88.7	0	.	p	.	0	G140R	NONSYN	418	420	GGA	950	952	AGA	123;123;122	A;G;A	112;112;108	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	570	porB1b	1041	1041	96.85	porB1b.l15.c17.ctg.1	1909	88.7	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	959	961	CAA	123;123;123	C;A;A	111;112;111	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	570	porB1b	1041	1041	96.85	porB1b.l15.c17.ctg.1	1909	88.7	0	.	p	.	0	I209M	NONSYN	625	627	ATC	1157	1159	ATG	118;119;121	A;T;G,C	98;100;101,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	570	porB1b	1041	1041	96.85	porB1b.l15.c17.ctg.1	1909	88.7	0	.	p	.	0	Q213P	NONSYN	637	639	CAG	1169	1171	CCA	118;119;121	C,T;C;A	101,1;102;102	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	570	porB1b	1041	1041	96.85	porB1b.l15.c17.ctg.1	1909	88.7	0	.	p	.	0	S216I	NONSYN	646	648	AGC	1178	1180	ATC	121;121;121	A;T;C	102;101;105	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	570	porB1b	1041	1041	96.85	porB1b.l15.c17.ctg.1	1909	88.7	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1289	1291	CAA	116;117;117	C;A;A	106;105;106	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	570	porB1b	1041	1041	96.85	porB1b.l15.c17.ctg.1	1909	88.7	0	.	p	.	0	.	INDELS	760	762	ACA	1293	1297	ATCAA	117;117;116;116;114	A;T;C;A;A	102;105;104;101;101	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	570	porB1b	1041	1041	96.85	porB1b.l15.c17.ctg.1	1909	88.7	0	.	p	.	0	.	INDELS	763	764	TG	1300	1302	AGT	114;114;114	A;G;T	102;102;100	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	570	porB1b	1041	1041	96.85	porB1b.l15.c17.ctg.1	1909	88.7	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1307	1309	GAT	113;112;113	G;A;T	99;100;100	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	570	porB1b	1041	1041	96.85	porB1b.l15.c17.ctg.1	1909	88.7	0	.	p	.	0	D293N	NONSYN	877	879	GAT	1415	1417	AAT	116;115;116	A;A;T	100;100;101	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	570	porB1b	1041	1041	96.85	porB1b.l15.c17.ctg.1	1909	88.7	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1421	1423	GAC	113;112;112	G;A;C	98;97;95	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	570	porB1b	1041	1041	96.85	porB1b.l15.c17.ctg.1	1909	88.7	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1424	1426	TAC	114;116;117	T;A;C	97;98;97	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2072	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5288	117.7	0	.	p	.	0	A1103V	NONSYN	3307	3309	GCC	3845	3847	GTC	129;128;128	G;T,C;C	112;111,1;112	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2072	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5288	117.7	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2195	2197	CAT	120;120;120	C;A,C;T	109;108,1;109	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	332	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1319	75.2	1	SNP	p	V57M	1	.	.	169	171	ATG	717	719	ATG	133;132;132	A;T;G	115;117;115	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
